Eli Lilly elects Jamere Jackson to board of directors

pharmafile | September 1, 2016 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, appointment 

Eli Lilly has elected Jamere Jackson to its board of directors, effective 1 October, where he will serve on the Audit and Finance committees.

Jackson has held positions at First Data Corporation, Total Systems Services, Pizza Hut and Proctor & Gamble Company. Most recently, he served as vice president and CFO for GE Oil & Gas, drilling and surface division and he currently holds the position of CFO at Nielsen Holdings.

“I am delighted to welcome Jamere Jackson to the Lilly board,” says John C. Lechleiter, chairman, president and chief executive officer at Eli Lilly. “Jamere brings a wealth of global financial experience, including a strong background in strategic planning. His experience at Nielsen will also provide an important perspective to our business and help broaden our understanding of consumer markets and strategies.”

Related Content

Eli Lilly shares results for tirzepatide for MASH resolution

Eli Lilly has announced results from the phase 2 SYNERGY-NASH study which assessed 190 patients, …

Eli Lilly and UNICEF expand support for young people at risk of noncommunicable diseases

Eli Lilly has announced that it will donate $6.5m to the United States Fund for …

Eli Lilly increases manufacturing investment to $9bn at new Indiana site

Eli Lilly has announced that it has more than doubled its investment at its Lebanon, …

Latest content